Program

In-person AND virtual! – We are pioneering a new conference format that will connect in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR is pushing the boundaries of innovation to design an event that works in today’s quickly changing environment. 

In-person registration included the full virtual experience, and virtual-only attendees will be able to tune into live in-person sessions and/or watch captured in-person sessions on-demand in addition to having a variety of virtual-only sessions to attend.

Characterization, Measurement, and Valuation of Attributes of Innovation of Technologies for Healthcare: A Systematic Review

Speaker(s)

Syeed MS1, Poudel N2, Ngorsuraches S3, Diaz J4, Chaiyakunapruk N1
1University of Utah, Salt Lake City, UT, USA, 2Auburn University, Auburn, AL, USA, 3Auburn University Harrison School of Pharmacy, Auburn, AL, USA, 4Bristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, UK

OBJECTIVES: Characterising and evaluating the holistic value of innovative healthcare technologies constitutes a crucial goal to maximize limited resources. However, there is a paucity of research attempting to systematically delve deeper into these characteristics of innovation. This review aims to describe the characteristics of healthcare innovation and how they have been defined, measured and/or valued from different perspectives.

METHODS: We searched PubMed, EMBASE, PsycINFO, and EconLit from inception to April 2021 to perform a 2-part systematic review. In the first part, studies that described healthcare innovation or its’ characteristics were included. Characteristics or definitions of innovation were extracted and conceptualized as attributes of innovation. In the second part, studies were included if they measured and/or valued the attributes of innovation.

RESULTS: In total, 101 articles were included in first part. Eight attributes describing innovation, i.e., novelty, step change, substantial benefits, an improvement over existing technologies, convenience and/or adherence, added value, acceptable cost, and uncounted benefits, were conceptualized. Seventeen articles were included in second part. When attributes were measured and traded-off relative to costs, they were defined as valuation. Substantial benefits and convenience and/or adherence attributes were measured by using adherence rate, life year/QALY gain, and overall innovativeness scale (e.g., point/binary scale). Cost-effectiveness analysis (CEA), rating, multiple criteria decision analysis (MCDA), and quality-adjusted cost of care (QACC), were used to value either substantial benefits or the convenience and/or adherence from payer perspective. To adequately capture the innovation, MCDA was found as a commonly recommended approach.

CONCLUSIONS: We identified eight attributes of innovation and found only two attributes, substantial benefits, and the convenience and/or adherence, were measured and/or valued from payer perspective. Existing valuation methods failed to include patient’s, caregiver’s and societal’s perspectives. Further research is warranted to obtain a better understanding of the healthcare innovation by the multiple stakeholders’ perspectives.

Code

HTA39

Topic

Health Technology Assessment, Study Approaches

Topic Subcategory

Literature Review & Synthesis, Value Frameworks & Dossier Format

Disease

No Additional Disease & Conditions/Specialized Treatment Areas